Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058790) titled 'A prospective registry for coronary artery plaque analysis and long-term prognosis investigation in patients undergoing cardiac catheterization: Goryokaku hospital ALLiance for OPtimal intervention in Coronary Artery Disease (GALLOP-CAD) Trial' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Hakodate Goryokaku Hospital, Department of Cardiology
Condition:
Condition - Coronary artery disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To understand the pathology of coronary artery disease at the patient and plaque levels
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who underwent coronary angiography or percutaneous coronary intervention
Key exclusion criteria - None
Target Size - 1000
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 07 Month 23 Day
Date of IRB - 2025 Year 07 Month 22 Day
Anticipated trial start date - 2025 Year 07 Month 23 Day
Last follow-up date - 2035 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067221
Disclaimer: Curated by HT Syndication.
